Skip to main content
Premium Trial:

Request an Annual Quote

BGI Extends Offer for Complete Genomics Until March 14

NEW YORK (GenomeWeb News) – BGI said today that it has extended its cash tender offer for Complete Genomics until 11:59 PM EDT, March 14.

The deadline for the approximately $118 million deal, which has been extended numerous times, previously had been midnight EST March 1. Last week BGI said that the Ministry of Commerce of the People's Republic of China had approved the deal but that it was still awaiting approval by China's State Administration of Foreign Exchange.

The depositary for the offer has indicated that as of the close of business on March 1, more than 30.7 million shares, or 87 percent, of Complete's stock had been validly tendered and not withdrawn, BGI said.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.